Saint Kitts and Nevis vs Sweden: Protecting minority investors: Ease of shareholder suits index (0-10)
Saint Kitts and Nevis
70
in 2013
Sweden
70
in 2013
Saint Kitts and Nevis rank
44th
Sweden rank
44th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Saint Kitts and Nevis
- Sweden
How they compare
Saint Kitts and Nevis currently reports 70 against 70 in Sweden, a difference of 0.
Across all 9 years both countries report, Sweden has been ahead every year.
Saint Kitts and Nevis ranks 44th and Sweden ranks 44th of 191 countries.
Head to head by decade
| Decade | Saint Kitts and Nevis | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70 | 70 | 0 | — |
| 2010s | 70 | 70 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Saint Kitts and Nevis or Sweden?
- Saint Kitts and Nevis, at 70 against 70 in Sweden as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Saint Kitts and Nevis and Sweden?
- 0, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Sweden?
- 9 years are reported by both, from 2005 to 2013.
- How do Saint Kitts and Nevis and Sweden rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Saint Kitts and Nevis ranks 44th and Sweden ranks 44th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.